# Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions

> **NCT01298947** · NA · UNKNOWN · sponsor: **Herz-Zentrums Bad Krozingen** · enrollment: 50 (estimated)

## Conditions studied

- Restenosis

## Interventions

- **DEVICE:** Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems

## Key facts

- **NCT ID:** NCT01298947
- **Lead sponsor:** Herz-Zentrums Bad Krozingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01298947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01298947, "Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01298947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*